Browse by author
Lookup NU author(s): Stuart Robinson, Professor Derek Manas, Professor Derek Mann, Steven White
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background: Liver resection remains the only chance of cure for patients with colorectal liver metastasis. Modern chemotherapy can play a role in the management of these patients but is not without risk. Methods: The online databases Medline and Pubmed were searched to identify relevant articles. Keywords used in these searches were "colorectal cancer'', "liver metastasis'', "chemotherapy'', "liver resection'', "monoclonal antibody'', "steatohepatitis'', "sinusoidal obstruction'' and "liver regeneration''. Databases were searched for the period January 1970 to September 2009 inclusively. In addition hand referencing of retrieved articles was performed. Results: Modern chemotherapy regimens can effectively downstage initially unresectable disease such that surgical resection can be performed with the prospect of long term cure. There is insufficient evidence however to recommend its use in either the neoadjuvant or adjuvant setting in those with resectable disease from the outset. Conclusion: Chemotherapy can be associated with significant changes to the hepatic parenchyma with subsequent increased risk of morbidity and mortality in the perioperative period. Much work needs to be done to understand the molecular mechanisms underlying these changes to make extended resections safer in patients who are at risk. (C) 2009 Elsevier Ltd. All rights reserved.
Author(s): Robinson S, Manas DM, Pedley I, Mann D, White SA
Publication type: Review
Publication status: Published
Journal: Surgical Oncology
Year: 2011
Volume: 20
Issue: 2
Pages: 57-72
ISSN (print): 0960-7404
ISSN (electronic): 1879-3320
Publisher: ELSEVIER SCI LTD
URL: http://dx.doi.org/10.1016/j.suronc.2009.10.002
DOI: 10.1016/j.suronc.2009.10.002
